Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52fbe46786eccd7c9c18838d42b097ce |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704 |
filingDate |
2007-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be9bafc6447d5410598e3ccec252dd61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d629093801491e5678bb135f80a07f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e28d135bb178a7667f9d63287ca88bfc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b50a12e804a4b2f0f78cdde68cce9d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65f99e7099dc9baa29c0762b0a118907 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d92f1aaaedf323d1537c0191474c9aae |
publicationDate |
2009-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2021333-A2 |
titleOfInvention |
Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
abstract |
The present invention is directed to molecules deriving from a 3-aryl-coumarine or 3-aryl-quinolin- 2-one and having potent anti-proliferative and/ or cytotoxic activity, especially against tumoral cells. The present invention also concerns the uses of these molecules in therapeutic application, for the treatment of different cancers. The invention also discloses the use of said compound for the manufacture of a medicament for treating cancer. The invention also concerns a process for inhibiting cell proliferation comprising contacting said cells with a compound of the invention. |
priorityDate |
2006-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |